Showing results (171-180 of 208) with videos related to

Sort By:
Pageof 21
British Journal of Anaesthesia|July 9, 2014
Xenon decreases cell migration and secretion of a pro-angiogenesis factor in breast adenocarcinoma cells: comparison with sevofluraneS A Ash, G I Valchev, M Looney, et al.
Arthritis Research & Therapy|July 15, 2011
The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cellsBetty Y Chang, Min Mei Huang, Michelle Francesco, et al.
Regional Anesthesia and Pain Medicine|October 27, 2010
Anesthetic technique and the cytokine and matrix metalloproteinase response to primary breast cancer surgeryCatherine A Deegan, David Murray, Peter Doran, et al.
Acta Crystallographica. Section D, Biological Crystallography|November 28, 2002
Expression, purification, crystallization and preliminary X-ray diffraction studies of human cathepsin F complexed with an irreversible vinyl sulfone inhibitorJoseph D Ho, Yana Meltser, Joseph J Buggy, et al.
Neoplasia (New York, N.Y.)|December 2, 2011
Modeling pharmacological inhibition of mast cell degranulation as a therapy for insulinomaLaura Soucek, Joseph J Buggy, Roderik Kortlever, et al.
British Journal of Anaesthesia|September 15, 2022
Postoperative recovery with continuous erector spinae plane block or video-assisted paravertebral block after minimally invasive thoracic surgery: a prospective, randomised controlled trialAneurin Moorthy, Aisling Ní Eochagáin, Eamon Dempsey, et al.
British Journal of Anaesthesia|July 4, 2020
Neutrophil extracellular trapping and angiogenesis biomarkers after intravenous or inhalation anaesthesia with or without intravenous lidocaine for breast cancer surgery: a prospective, randomised trialElena V Galoș, Tiberiu-Florin Tat, Răzvan Popa, et al.
Frontiers in Oncology|April 1, 2022
Solid Tumor Opioid Receptor Expression and Oncologic Outcomes: Analysis of the Cancer Genome Atlas and Genotype Tissue Expression ProjectAmparo Belltall, Sheila Zúñiga-Trejos, Iris Garrido-Cano, et al.
Blood|January 27, 2012
The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemiaMartin F M de Rooij, Annemieke Kuil, Christian R Geest, et al.
Molecular Cancer Therapeutics|May 30, 2006
CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivoJoseph J Buggy, Z Alexander Cao, Kathryn E Bass, et al.
Pageof 21